Neil Laycock, Managing Director of Healthcare, Servelec, explores the potential for digital solutions to change the narrative on managing precious assets in the healthcare environment.
Here, we look at medical devices policy of Japan’s Ministry of Health, Labour and Welfare. The Ministry now has Katsunobu Katō in place, who very recently replaced Nemoto Takumi as the Minister of Health, Labour and Welfare in the country.
The role of the Canadian Institutes of Health Research, when it comes to funding health research in Canada, is explored here, including a look at the work of the Human Development, Child and Youth Health division within that.
Cosmo Feilding Mellen, Managing Director of Spectrum Therapeutics UK looks at access to medical cannabis and to what extent is medical cannabis now legalised.
The NHS Confederation and Amnesty International respond to the Queen's Speech, highlighting elements such as a credible domestic agenda and a need for immigration reform.
For a long time the causes of acute coronary syndromes were poorly understood, and, only after the publication of our paper on New England Journal of Medicine on the importance of inflammation it was recognised as a crucial pathogenetic mechanism.
Carolyn R. Klocke and Pamela J. Lein discuss how an individual’s experiences during early life can influence their risk for disease as an adult.
Here, Cecile ten Kate discusses the process of valorisation of research projects, focusing specifically on the health innovation ecosystem.
After a career spanning more than 20 years, a Swansea University Professor’s passion for research is as ‘strong as ever’, as he marks a very notable achievement – the release of his 100th cancer research paper.
Savage Cabbage Ltd offer their expert advice on what dosage CBD users should be taking and answers other often asked questions, in this in-depth article.
Here, the tangible impact on diabetes patients and their care is thoroughly explored via integrated personalised diabetes management (iPDM).
In the second of a series of five articles, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine.
Koichi Watashi, Senior Researcher from the National Institute of Infectious Diseases, Japan, explores the trick for cell invasion in reaching regulation of hepatitis B entry.
John Wallace, Managing Director of Mile High Labs, International, shares with us why CBD continues to be one of the most exciting new products to hit the marketplace and focuses here on some significant numbers in the field.
Here, Dr Masanori Katakura from the Laboratory of Nutritional Physiology, explains the importance of keeping the kidneys healthy, as well as the surprisingly common condition, chronic kidney disease (CKD).
Here, we find out about the highest-scoring supplier – Jones AV Ltd, who discuss the New SBS Framework: Audio Visual Solutions and Integrated Operating Theatres.
Here, experts explain the intricate situation of Dementia care in Hong Kong, and why it could benefit from a train-the-trainer approach.
Brendan Crossey, Chief Executive Officer of Healthcare Analytics Limited, directs our thoughts to innovative bed tracking at the Northern Health and Social Care Trust, one of five health and social care trusts in Northern Ireland.
GreenLight Medicines is a supplier of quality supplements and is an active MedCan research company GreenLight, Supplements and Medicines.
In this article, Dr Hans-Günter Weeß explains the connection between sleep, mental health and strengthening resilience.